Navigation Links
Shire Proposes to Expand Specialist Gastrointestinal Portfolio
Date:8/3/2010

ment several years ago of a dedicated GI business unit. Shire's proposed acquisition of Movetis brings rights to the recently approved RESOLOR in Europe as well as world-class research and development talent and a promising GI pipeline, offering additional opportunities for Shire. The acquisition will expand the growth of Shire's marketed GI product portfolio internationally.

RESOLOR is a selective, high-affinity 5-HT(4) receptor agonist specifically developed to target impaired motility associated with chronic constipation. It has composition of matter patent protection extending through 2020 and Shire estimates potential peak sales of over EUR300 million. The patients in this category are generally served by specialist gastroenterologists. Other marketed treatments for this condition are limited or have associated serious adverse effects. In addition to RESOLOR, Movetis has two projects in early clinical development and several pre-clinical leads as well as the rights to a large library of qualified lead compounds with potential for development and commercialization by Movetis in global markets in different GI indications.

About Movetis

Movetis is a European specialty GI company that is focused on improving the lives of millions of patients - both adults and children - by discovering, developing and commercialising innovative treatments targeting GI conditions with a high unmet medical need. Movetis NV was founded in Belgium in November 2006 as a spin-off of Johnson & Johnson. Movetis has a broad portfolio of GI products: Beside Resolor(R) (prucalopride), Movetis has two products in Phase 2 development and two prioritised compounds in preclinical development, all addressing important GI areas including ascites, paediatric
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
2. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
3. Shire plc Appoints Two New Board Directors
4. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
5. Shire Receives 2010 Corporate Award From the National Organization for Rare Disorders (NORD) for the Development of VPRIV (velaglucerase alfa for Injection)
6. INTUNIV(TM) - Shire Files Suit Against Actavis Elizabeth LLC and Actavis Inc.
7. Shires Replenished Portfolio Drives Excellent Quarterly Performance
8. Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals
9. Shire Supports Rare Disease Day 2010
10. Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease
11. Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., ... needs in epilepsy and related neurological disorders, is today ... its lead compound INS001 in patients with drug-resistant epilepsy.  ... and Device Trials (AED) Xll meeting by Dr. ... and Chairman of Insero,s Scientific Advisory Board.  In this ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 RURO ... ezColony version 4.1, a versatile refinement to the ... software solution, improves its advanced methodical management for ... with ezColony 4.1. The network-based platform provides user ... effective research. While continuing to emphasize streamlined tasks, ...
(Date:5/17/2013)... WA (PRWEB) May 17, 2013 Tooth decay ... graders showing active signs of the disease. The World Health ... and nearly 100% of adults have cavities. What are the ... is showing a strong connection between the oral bacterial ... is this disease so rampant, yet it is also 100% ...
(Date:5/16/2013)... Oven Industries, Inc. has been an industry ... sensors since 1964. Expertly designed, the proportional-integral-derivative PID ... applications. As one of the most commonly ... loop feedback system, which helps minimize errors. With three-term ... systematic process, using a control element, like a valve ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3New PID Temperature Controllers Announced by Oven Industries Inc. 2
... This release is available in German . ... electric vehicles can be halved by 2018, if the gaps ... objective, KIT scientists develop concrete, close-to-industry solutions for energy stores ... A close-to-industry "research factory" is planned to be constructed on ...
... PharmaVentures Limited, experts in deals and alliances, ... engaged by leading drug discovery company, Astex Pharmaceuticals ... service CMC (chemistry, manufacturing & controls) & Formulation ... PharmaVentures, asset divestment expertise in the life sciences ...
... PRINCETON, N.J., Sept. 8, 2011 Laureate ... Group (RSG) has been approved by the Food and ... (eCTD) regulatory submissions to the Agency. The 4 gigabyte ... reviewed, validated and approved without errors and in record ...
Cached Biology Technology:IAA 2011: Reducing costs of electric vehicle batteries 2FDA Approves Electronic Common Technical Document (eCTD) for Laureate's Regulatory Submissions 2FDA Approves Electronic Common Technical Document (eCTD) for Laureate's Regulatory Submissions 3
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... Biology (SDB) 72nd Annual Meeting in Cancun, Mexico ... to promote the entry of students, postdoctorates and ... the basic science community and to encourage the ... Annual Meeting. , Awards are given to poster/platform ...
(Date:5/16/2013)... MIT may someday eliminate the need for patients ... blood-sugar levels and inject themselves with insulin. , ... in the body and respond by secreting the ... of pancreatic islet cells, which are destroyed in ... of system could ensure that blood-sugar levels remain ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... used in bone marrow transplantation can develop into new ... Yale School of Medicine in the Proceedings of the ... bone marrow derived cells can differentiate into functional gastrointestinal ... the laboratory of Diane Krause, M.D., professor of Laboratory ...
... antibiotic commonly used to treat a variety of serious infections ... a test-tube study of human brain cells by Johns Hopkins ... Results of the lab study with ceftriaxone are expected to ... meeting on April 5 in San Diego, Calif. , Rumbaugh ...
... 60 and 60 is the new 50, unfortunately for much ... simply isn't true. , New research however from The University ... means to maintain muscle function and quality of life in ... as simple as taking a stroll followed by a glass ...
Cached Biology News:Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients 2Chocolate milk could be key to longer, healthier life 2
... maintenance, calibration, and validation (MCV) ... 96-well plate used for hands-free ... procedures using the Bio-Plex suspension ... is for use with Bio-Plex ...
Mynox is intended for research use only. Mynox is used for the elimination of Mycoplasma and Acholeplasma in cell and virus cultures, and other biologicals....
... The MiniOpticon 2-color real-time PCR detection system ... 48-well microplate. An array of 48 LEDs independently ... a pair of filtered photodiodes detects emitted light ... built on a MJ Mini cycler, whose Peltier ...
... system holds 48 x 0.2 ml tubes, or a ... fluorescence (470-500 nm) for each well, and a pair ... 540-700 nm). This item is a real-time upgrade for ... are 18 x 32 x 33 cm (W x ...
Biology Products: